A comparison of the effects of Angiotensin IV on androgen-dependent and androgen-independent prostate cancer cell lines

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 14, Issue 1, 2013, Pages 74-81

  Domińska, Kamila ^a   Piastowska Ciesielska, Agnieszka W ^a   Płuciennik, Elzbieta ^a   Lachowicz Ochȩdalska, Agnieszka ^a   Ochȩdalski, Tomasz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Angiotensin IV; AT1; AT2; cell proliferation; prostate cancer

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANDROGEN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II [3-8]; ANGIOTENSIN RECEPTOR; BROXURIDINE; LOSARTAN;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PROSTATE CANCER; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANDROGENS; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN II TYPE 2 RECEPTOR BLOCKERS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN;

EID: 84874058729     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320312447649     Document Type: Article

References (40)

1. Dinh DT, Frauman AG, Sourial M, et al. Identification, distribution, and expression of angiotensin II receptors in the normal human prostate and benign prostatic hyperplasia. Endocrinology. 2001 ; 142: 1349-1356
2. O'Mahony OA, Barker S, Puddefoot JR, et al. Synthesis and secretion of angiotensin II by the prostate gland in vitro. Endocrinology. 2005 ; 146: 392-398
3. Domińska K, Lachowicz-Ochȩdalska A. The involvement of the renin angiotensin system (RAS) in cancerogenesis. Postepy Biochem. 2008 ; 54: 294-300
4. Piastowska-Ciesielska AW, Drobnik J, Zarzyńska J, et al. Influence of myocardial infarction on changes in the expression of angiotensin type 1 receptor in the rat prostate. Folia Histochem Cytobiol. 2011 ; 49: 497-503
5. Piastowska-Ciesielska AW, Płuciennik E, Wójcik-Krowiranda, et al. Analysis of the expression of angiotensin II type 1 receptor and VEGF in endometrial adenocarcinoma with different clinicopathological characteristics. Tumour Biol. 2012 ; 33: 767-774
6. Nassis L, Frauman AG, Ohishi M, et al. Localization of angiotensin-converting enzyme in the human prostate: Pathological expression in benign prostatic hyperplasia. J Pathol. 2001 ; 195: 571-579
7. Dinh DT, Frauman AG, Casley DJ, et al. Angiotensin AT(4) receptors in the normal human and benign prostatic hyperplasia. Mol Cell Endocrinol. 2001 ; 184: 187-192
8. Louis SN, Wang L, Chow L, et al. Appearance of angiotensin II expression in nonbasal epithelial cells is an early feature of malignant change in human prostate. Cancer Detect Prev. 2007 ; 31: 391-395
9. Dinh DT, Frauman AG, Somers GR, et al. Evidence for activation of the renin-angiotensin system in the human prostate: Increased angiotensin II and reduced AT(1) receptor expression in benign prostatic hyperplasia. J Pathol. 2002 ; 196: 213-219
10. Haulica I, Bild W, Serban DN. Angiotensin peptides and their pleiotropic actions. J Renin Angiotensin Aldosterone Syst. 2005 ; 6: 121-131
11. Kumar R, Singh VP, Baker KM. The intracellular renin-angiotensin system: A new paradigm. Trends Endocrinol Metab. 2007 ; 18: 208-214
12. Mustafa T, Lee JH, Chai SY, et al. Bioactive angiotensin peptides: focus on angiotensin IV. J Renin Angiotensin Aldosterone Syst. 2001 ; 2: 205-210
13. Vauquelin G, Michotte Y, Smolders I, et al. Cellular targets for angiotensin II fragments: Pharmacological and molecular evidence. J Renin Angiotensin Aldosterone Syst. 2002 ; 3: 195-204
14. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002 ; 30: e36
15. Chow L, Rezmann L, Catt KJ, et al. Role of the renin- angiotensin system in prostate cancer. Mol Cell Endocrinol. 2009 ; 302: 219-229
16. Sobel RE, Sadar MD. Cell lines used in prostate cancer research: A compendium of old and new lines. J Urol. 2005 ; 173: 342-359
17. Siejka A, Mełeń-Mucha G, Mucha SA, et al. Angiotensins II and IV modulate adrenocortical cell proliferation in ovariectomized rats. J Physiol Pharmacol. 2006 ; 57: 451-461
18. Leung PS, Sernia C. The renin-angiotensin system and male reproduction: New functions for old hormones. J Mol Endocrinol. 2003 ; 30: 263-270
19. Lachowicz A, Ochȩdalski T, Rȩbas E. Steroid modulation of angiotensin II action in the rat anterior pituitary gland. Neuro Endocrinol Lett. 2003 ; 24: 91-95
20. Lachowicz A, Ochȩdalski T, Pawlikowski M, et al. Effect of 17-beta-estradiol and progesterone on angiotensin II-induced changes in inositol-1,4,5-trisphosphate content and protein kinase C activity in anterior pituitary. Biochem Biophys Res Commun. 2000 ; 275: 7-10
21. Pawlikowski M, Kunert-Radek J. Angiotensin IV stimulates the proliferation of rat anterior pituitary cells in vitro. Biochem Biophys Res Commun. 1997 ; 17: 292-293
22. Ptasinska-Wnuk D, Kunert-Radek J, Pawlikowski M. Angiotensins II and IV stimulate the rat anterior pituitary cell proliferation independently of the AT1 receptor subtype. Neuroendocrinol Lett. 2003 ; 24: 397-400
23. Wang L, Eberhard M, Erne P. Stimulation of DNA and RNA synthesis in cultured rabbit cardiac fibroblasts by angiotensin IV. Clin Sci. 1995 ; 88: 557-562
24. Li YD, Block ER, Patel JM. Activation of multiple signaling modules is critical in angiotensin IV-induced lung endothelial cell proliferation. Am J Physiol Lung Cell Mol Physiol. 2002 ; 283: 707-716
25. Pawlikowski M, Mełeń-Mucha G, Mucha S. The involvement of the renin-angiotensin system in the regulation of cell proliferation in the rat endometrium. Cell Mol Life Sci. 1999 ; 55: 506-510
26. Pawlikowski M, Gruszka A, Mucha S, et al. Angiotensins II and IV stimulate the rat adrenocortical cell proliferation acting via different receptors. Endocr Regul. 2001 ; 35: 139-142
27. Moeller I, Small DH, Reed G, et al. Angiotensin IV inhibits neurite outgrowth in cultured embryonic chicken sympathetic neurons. Brain Res. 1996 ; 725: 61-66
28. Ławnicka H, Potocka AM, Juzala A, et al. Angiotensin II and its fragments (angiotensins III and IV) decrease the growth of DU-145 prostate cancer in vitro. Med Sci Monit. 2004 ; 10: 410-413
29. Ptasińska-Wnuk D, Ławnicka H, Fryczak J, et al. Angiotensin eptides regulate angiogenic activity in rat anterior ituitary tumour cell cultures. Endokrynol Pol. 2007 ; 58: 478-486
30. Domińska K, Piastowska AW, Rȩbas E, et al. The influence of peptides from angiotensin family on tyrosine kinase activity and cell viability in human hormone-dependent prostate cancer line. Endokrynol Pol. 2009 ; 60: 363-369
31. Le MT, Vanderheyden PM, Szaszák M, et al. Angiotensin IV is a potent agonist for constitutive active human AT1 receptors. Distinct roles of the N- and C-terminal residues of angiotensin II during AT1 receptor activation. J Biol Chem. 2002 ; 277: 23107-23110
32. Funao K, Matsuyama M, Kawahito Y, et al. Telmisartan is a potent target for prevention and treatment in human prostate cancer. Oncol Rep. 2008 ; 20: 295-300
33. Ino K, Shibata K, Kajiyama H, et al. Manipulating the angiotensin system - new approaches to the treatment of solid tumours. Expert Opin Biol Ther. 2006 ; 6: 243-255
34. Deshayes F, Nahmias C. Angiotensin receptors: A new role in cancer?. Trends Endocrinol Metab. 2005 ; 16: 293-299
35. Verras M, Lee J, Xue H, et al. The androgen receptor negatively regulates the expression of c-Met: Implications for a novel mechanism of prostate cancer progression. Cancer Res. 2007 ; 67: 967-975
36. Vanderheyden PM. From angiotensin IV binding site to AT4 receptor. Mol Cell Endocrinol. 2009 ; 302: 159-166
37. Knudsen BS, Gmyrek GA, Inra J, et al. High expression of the Met receptor in prostate cancer metastasis to bone. Urology. 2002 ; 60: 1113-1117
38. Chow L, Rezmann L, Imamura K, et al. Functional angiotensin II type 2 receptors inhibit growth factor signaling in LNCaP and PC3 prostate cancer cell lines. Prostate. 2008 ; 68: 651-660
39. Sidorkiewicz M, Rȩbas E, Szymajda M, et al. Angiotensin receptors in hormone-independent prostate cancer cell line DU145: Presence of two variants of angiotensin type 1 receptor. Med Sci Monit. 2009 ; 15: BR106 - BR110
40. Cresci B, Giannini S, Pala L, et al. AT1 and AT2 receptors in human glomerular endothelial cells at different passages. Microvasc Res. 2003 ; 66: 22-29